Cargando…

Product review on the IMD serogroup B vaccine Bexsero®

Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates. When administered alone, Bexsero® showed a safety profile similar to othe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deghmane, Ala-Eddine, Taha, Muhamed-Kheir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Meningococcal – Product Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986181/ https://www.ncbi.nlm.nih.gov/pubmed/35192786 http://dx.doi.org/10.1080/21645515.2021.2020043

Ejemplares similares

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

Changing patterns of invasive meningococcal disease and future immunization strategies
por: Taha, Muhamed-Kheir, et al.
Publicado: (2023)

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
por: Taha, Samy, et al.
Publicado: (2022)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review
por: Deghmane, Ala-Eddine, et al.
Publicado: (2021)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
por: Hong, Eva, et al.
Publicado: (2016)

Neisseria meningitidis Serogroup X in Sub-Saharan Africa
por: Agnememel, Alain, et al.
Publicado: (2016)

Draft Genome Sequence of a Neisseria meningitidis Serogroup C Isolate of Sequence Type 11 Linked to an Outbreak among Men Who Have Sex with Men
por: Veyrier, Frédéric J., et al.
Publicado: (2013)

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Pandemic’s influence on parents’ attitudes and behaviors toward meningococcal vaccination
por: Tan, Litjen (L.J), et al.
Publicado: (2023)

Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease
por: Taha, Muhamed-Kheir, et al.
Publicado: (2020)

Difference in virulence between Neisseria meningitidis serogroups W and Y in transgenic mice
por: Eriksson, Lorraine, et al.
Publicado: (2020)

Travel-related Neisseria meningitidis Serogroup W135 Infection, France
por: Taha, Muhamed-Kheir, et al.
Publicado: (2013)

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
por: Robertson, Corwin A., et al.
Publicado: (2023)

Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam
por: The Nguyen, Phung Nguyen, et al.
Publicado: (2023)

Meningococcal burden of disease in Argentina: 10 years epidemiologic review
por: Neyro, Silvina, et al.
Publicado: (2023)

Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries
por: Taha, Muhamed-Kheir, et al.
Publicado: (2020)

Recent Evolution of Susceptibility to Beta-Lactams in Neisseria meningitidis
por: Deghmane, Ala-Eddine, et al.
Publicado: (2023)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
por: Dubey, Anand P., et al.
Publicado: (2022)

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Weil-Olivier, Catherine, et al.
Publicado: (2022)

Meningococcal disease within the Gulf Cooperation Council Countries
por: Al Awaidy, Salah, et al.
Publicado: (2023)

Real-world impact and effectiveness of MenACWY-TT
por: Villena, Rodolfo, et al.
Publicado: (2023)

Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitis
por: Guiddir, Tamazoust, et al.
Publicado: (2014)

Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
por: Hong, Eva, et al.
Publicado: (2021)

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017
por: Bassi, Clément, et al.
Publicado: (2017)

Late Repression of NF-κB Activity by Invasive but Not Non-Invasive Meningococcal Isolates Is Required to Display Apoptosis of Epithelial Cells
por: Deghmane, Ala-Eddine, et al.
Publicado: (2011)

Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain
por: Pérez-Trallero, Emilio, et al.
Publicado: (2014)

The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein
por: Mubaiwa, Tsitsi D., et al.
Publicado: (2018)

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age
por: Marshall, Gary S., et al.
Publicado: (2022)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
por: Knuf, Markus, et al.
Publicado: (2022)

Differential Modulation of TNF-α–Induced Apoptosis by Neisseria meningitidis
por: Deghmane, Ala-Eddine, et al.
Publicado: (2009)

Preventing invasive meningococcal disease in early infancy
por: Presa, Jessica, et al.
Publicado: (2022)

Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
por: Breton, Marie-Claude, et al.
Publicado: (2020)

Hyperinvasive Meningococci Induce Intra-nuclear Cleavage of the NF-κB Protein p65/RelA by Meningococcal IgA Protease
por: Besbes, Anissa, et al.
Publicado: (2015)

Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015
por: Kretz, Cecilia B., et al.
Publicado: (2016)

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
por: Tzanakaki, Georgina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_at8uv2s9m4vja1kt4mlt9nd05u